Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Hongjin Xiaojie
- Development stage
- Phase 4
- Lead developer
- Yunnan Yousheng Pharmaceutical
- Administration
- Oral
01
Overview
Hongjin Xiaojie is a traditional Chinese medicine (TCM) patent formulation, typically administered as a capsule. It is composed of multiple herbal ingredients, including *Bupleurum chinense*, *Panax notoginseng*, *Cyperus rotundus*, and others. In TCM theory, it is used to soothe the liver, regulate Qi, and resolve blood stasis. Clinically, it is primarily indicated for the treatment of breast hyperplasia (cyclical breast pain), uterine fibroids (myoma), and ovarian cysts. It is currently being evaluated in real-world studies as a comparator for alternative TCM therapies like Kou Sha.
- Brand names
- Hongjin Xiaojie Capsule
- Other names
- HJXJCHongjin Xiaojie Jiaonang
Beyond the preview
Go deeper on Hongjin Xiaojie.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Hongjin Xiaojie.